Addus HomeCare (ADUS) to Release Quarterly Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is set to issue its quarterly earnings data after the market closes on Monday, August 5th. Analysts expect the company to announce earnings of $1.04 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same period in the prior year, the business posted $0.84 earnings per share. The company’s revenue was up 11.6% on a year-over-year basis. On average, analysts expect Addus HomeCare to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Addus HomeCare Trading Down 1.3 %

Shares of ADUS opened at $120.32 on Friday. The business’s 50-day moving average price is $118.06 and its 200-day moving average price is $104.76. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $125.24. The stock has a market cap of $2.18 billion, a PE ratio of 29.86, a P/E/G ratio of 2.35 and a beta of 1.01. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

ADUS has been the topic of several analyst reports. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Barclays cut shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a research report on Tuesday, April 23rd. Oppenheimer upped their price objective on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Stephens upped their price objective on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a research report on Friday, May 31st. Finally, Bank of America upped their price objective on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and an average price target of $117.86.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.